Previous 10 | Next 10 |
Tortoise Acquisition (NYSE: SHLL ) -9% . More news on: Tortoise Acquisition Corp., Auris Medical Holding Ltd., Digital Turbine, Inc., Stocks on the move, , Read more ...
Thinly traded nano cap Auris Medical ( EARS +27.7% ) jumps on a whopping 130x surge in volume in reaction to positive preliminary results from a Phase 2 clinical trial, TRAVERS , evaluating lead candidate AM-125 (betahistine) for the treatment of patients with acute peripheral vertigo f...
Dose dependent improvement in balance tests over placebo in Part A of TRAVERS trial Improvement 1.9 to 2.4 times greater with highest dose than with placebo Trial to proceed with Part B to test AM-125 10 and 20 mg vs. placebo Hamilton, Bermuda, September 3, 2020 – Auris ...
Hamilton, Bermuda, August 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has regained complianc...
Dose escalation completed as last patient enrolled into Part A of TRAVERS study Interim results to be announced in Q3 of 2020 Hamilton, Bermuda, July 29, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address ...
Administration of intranasal betahistine 30 mg shows statistically significant reduction in olanzapine-induced weight gain Treatment well tolerated and safe with no adverse effects Enrollment into Phase 2 TRAVERS trial with AM-125 resumed following break due to COVID-19 pandemic Hamil...
Phase 1b trial with intranasal betahistine for prevention of antipsychotic-induced weight gain progressing towards final read-out Phase 2 trial with intranasal betahistine for treatment of acute vertigo progressing towards interim analysis, but temporarily slowed down by COVID-19 impact ...
Phase 1b trial with AM-201 proceeding as planned to data read-out in early May 2020 Enrollment into Phase 2 trial with AM-125 impacted by COVID-19 pandemic Company to report 2019 second-half and full year results and provide general business update on April 16, 2020 Hamilton, B...
Hamilton, Bermuda, February 25, 2020 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today highlighted the publication of an article descr...
Sorrento Therapeutics (NASDAQ: SRNE ) +50% on non-binding takeover bid . More news on: Sorrento Therapeutics, Inc., Aclaris Therapeutics, Inc., AzurRx BioPharma, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Auris Medical Holding AG Company Name:
EARS Stock Symbol:
NASDAQ Market:
LAS VEGAS, NV - ( NewMediaWire ) - April 04, 2022 - Digipath, Inc. (OTCQB: DIGP) (“Digipath” or the “Company”), a service-oriented independent analytical testing laboratory, data analytics firm focused on the cannabis and hemp markets is pleased to annou...
Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the launch of its newly-designed corporate...
Are These Reddit Penny Stocks on Your Watchlist in 2021? Reddit penny stocks have become commonplace talking points in the stock market over the past year and a half. While the clear reason for this is heightened interest in the stock market, there are a couple of other reasons to consi...